Sphera Funds Management Ltd. 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Sphera Funds Management Ltd. disclosed 101 US equity positions worth $421.6m in its Q3 2025 13F filing. The largest position was TEVA at 7.2% of the reported book, followed by NICE and TSEM. Against the Q2 2025 filing, it opened 7 new positions, added to 11 and reduced 19 among the top 50 holdings.
What did Sphera Funds Management Ltd. own in Q3 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 7.2% | $30.4m | 1,507,025 | -7% | reduced |
| 2 | NICE NICE LTD | Technology | 5.4% | $22.8m | 157,400 | – | new |
| 3 | TSEM TOWER SEMICONDUCTOR LTD | Technology | 5.3% | $22.5m | 311,802 | 18% | added |
| 4 | NVMI NOVA LTD | Technology | 3.3% | $14.0m | 43,896 | -42% | reduced |
| 5 | QQQ INVESCO QQQ TR | 3.3% | $13.8m | 22,960 | – | new | |
| 6 | BIIB BIOGEN INC | Healthcare | 2.7% | $11.6m | 82,738 | 0% | held |
| 7 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 2.5% | $10.6m | 352,558 | 252% | added |
| 8 | AZN ASTRAZENECA PLC | Healthcare | 2.5% | $10.4m | 135,060 | 0% | held |
| 9 | SNY SANOFI SA | 2.5% | $10.4m | 219,515 | 0% | held | |
| 10 | CYTK CYTOKINETICS INC | Healthcare | 2.1% | $8.9m | 161,517 | -51% | reduced |
| 11 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 2.0% | $8.3m | 219,910 | -54% | reduced |
| 12 | AM6 AMICUS THERAPEUTICS INC | 1.9% | $7.8m | 991,142 | 0% | held | |
| 13 | LLY ELI LILLY & CO | Healthcare | 1.8% | $7.7m | 10,040 | -13% | reduced |
| 14 | JNJ JOHNSON & JOHNSON | Healthcare | 1.8% | $7.6m | 40,831 | 0% | held |
| 15 | CDTX CIDARA THERAPEUTICS INC | 1.7% | $7.3m | 75,743 | -45% | reduced | |
| 16 | FBRX FORTE BIOSCIENCES INC | 1.7% | $7.1m | 474,309 | -4% | reduced | |
| 17 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 1.4% | $6.0m | 387,716 | -75% | reduced |
| 18 | TRVI TREVI THERAPEUTICS INC | Healthcare | 1.4% | $5.9m | 643,957 | -20% | reduced |
| 19 | NVO NOVO-NORDISK A S | Healthcare | 1.4% | $5.9m | 105,677 | 0% | held |
| 20 | ABBV ABBVIE INC | Healthcare | 1.4% | $5.8m | 25,256 | 0% | held |
| 21 | CLBT CELLEBRITE DI LTD | Technology | 1.3% | $5.5m | 298,948 | – | new |
| 22 | ANNX ANNEXON INC | Healthcare | 1.3% | $5.5m | 1,794,387 | 2% | added |
| 23 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.3% | $5.4m | 426,518 | 93% | added |
| 24 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.3% | $5.4m | 207,764 | -50% | reduced |
| 25 | SOLAREDGE TECHNOLOGIES INC | 1.3% | $5.3m | 4,000,000 | – | new | |
| 26 | GSK GSK PLC | Healthcare | 1.2% | $5.3m | 122,000 | 0% | held |
| 27 | SEDG SOLAREDGE TECHNOLOGIES INC | Technology | 1.2% | $5.2m | 140,966 | 10% | added |
| 28 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 1.2% | $5.2m | 431,693 | 9% | added |
| 29 | IMTX IMMATICS N.V | Healthcare | 1.2% | $5.0m | 583,105 | 0% | held |
| 30 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 1.2% | $4.9m | 173,931 | 81% | added |
| 31 | SVRA SAVARA INC | Healthcare | 1.1% | $4.8m | 1,350,333 | 3% | added |
| 32 | NVS NOVARTIS AG | Healthcare | 1.1% | $4.7m | 37,000 | 0% | held |
| 33 | RAPP RAPPORT THERAPEUTICS INC | 1.1% | $4.7m | 157,533 | – | new | |
| 34 | VRNS VARONIS SYS INC | Technology | 1.0% | $4.2m | 73,900 | – | new |
| 35 | IMVT IMMUNOVANT INC | Healthcare | 1.0% | $4.1m | 256,743 | 0% | held |
| 36 | MRK MERCK & CO INC | Healthcare | 1.0% | $4.1m | 48,600 | 0% | held |
| 37 | MAZE MAZE THERAPEUTICS INC | 0.9% | $4.0m | 154,343 | -57% | reduced | |
| 38 | ENGENE HOLDINGS INC | 0.8% | $3.4m | 504,409 | 0% | held | |
| 39 | ELBIT SYS LTD | 0.8% | $3.4m | 6,740 | 12% | added | |
| 40 | RZLT REZOLUTE INC | 0.8% | $3.4m | 363,947 | -52% | reduced | |
| 41 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 0.8% | $3.4m | 166,765 | 30% | added |
| 42 | MDWD MEDIWOUND LTD | Healthcare | 0.8% | $3.3m | 185,270 | – | new |
| 43 | ELDN ELEDON PHARMACEUTICALS INC | 0.8% | $3.3m | 1,280,233 | -35% | reduced | |
| 44 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 0.8% | $3.2m | 148,900 | -15% | reduced |
| 45 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 0.7% | $3.1m | 57,901 | -47% | reduced |
| 46 | CAMT CAMTEK LTD | Technology | 0.7% | $3.1m | 29,048 | -9% | reduced |
| 47 | AMZN AMAZON COM INC | Consumer Cyclical | 0.7% | $3.0m | 13,760 | -58% | reduced |
| 48 | CRVS CORVUS PHARMACEUTICALS INC | Healthcare | 0.7% | $3.0m | 407,709 | 123% | added |
| 49 | PHVS PHARVARIS N V | 0.7% | $3.0m | 119,406 | -61% | reduced | |
| 50 | META META PLATFORMS INC | Communication Services | 0.7% | $2.9m | 3,924 | -54% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.